Genprex Announces 1-for-40 Reverse Stock Split Effective Feb

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Related Keywords

Texas , United States , , Genprex Inc , Vstock Transfer , Company Website , Facebook , Linkedin , Company Board Of Directors The , Exchange Commission , Company Board , Prnewswire Genprex Inc , Nasdaq Capital , Nanoparticle Delivery System , Immunogene Therapy , Fast Track Designation , Language Concerning Forward Looking Statements , Private Securities Litigation Reform Act , Annual Report , Nasdaq Capital Market , Genprex , Nc , Pharmaceuticals , Health Care Amp Hospitals , Medical Pharmaceuticals , Stock Split ,